Cardiotrophin-1 is a prophylactic against the development of chronic hypoxic pulmonary hypertension in rats

Annals of Thoracic Surgery

Volumn 76, Issue 1, 2003, Pages 237-243

  Nomura, Norikazu ^a   Asano, Miki ^a   Saito, Takayuki ^a   Sasaki, Shigeru ^a   Suzuki, Hikaru ^a   Manabe, Tadao ^a   Mishima, Akira ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTROPHIN 1; ENDOTHELIUM DERIVED RELAXING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART PROTECTION; HEART RIGHT VENTRICLE HYPERTROPHY; HYPOXIA; LUNG ARTERY PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; SPECIES COMPARISON; STATISTICAL ANALYSIS;

ANALYSIS OF VARIANCE; ANIMALS; ANOXIA; CHRONIC DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; HEMODYNAMIC PROCESSES; HYPERTENSION, PULMONARY; MALE; NITRIC OXIDE SYNTHASE; PROBABILITY; PULMONARY ARTERY; PULMONARY GAS EXCHANGE; RANDOM ALLOCATION; RATS; RATS, WISTAR; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VASODILATION;

EID: 0037999918     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)00339-4     Document Type: Article

References (29)

1. Jin H, Yang R, Ko A, Pennica D, Wood WI, Paoni NF. Effects of cardiotrophin-1 on haemodynamics and cardiac function in conscious rats. Cytokine 1998;10:19-25.
2. G-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension. Crit Care Med 1995;23:1018-24.
3. Pulido EJ, Shames BD, Pennica D, et al. Cardiotrophin-1 attenuates endotoxin-induced acute lung injury. J Surg Res 1999;84:240-6.
4. Pennica D, Shaw KJ, Swanson TA, et al. Cardiotrophin-1 biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem 1995;270:10915-22.
5. Wollert KC, Taga T, Saito M, et al. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series via gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem 1996;271:9535-45.
6. Sheng Z, Knowlton K, Chen J, Hoshijima M, Brown JH, Chien KR. Cardiotrophin-1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway: divergence from downstream CT-1 signals for myocardial cell hypertrophy. J Biol Chem 1997;272:5783-91.
7. Ghosh S, Ng LL, Talwar S, Squire IB, Galinanes M. Cardiotrophin-1 protects the human myocardium from ischemic injury: comparison with the first and second window of protection by ischemic preconditioning. Cardiovasc Res 2000;48:440-7.
8. Pennica D, King KL, Shaw KJ, et al. Expression cloning of cardiotrophin-1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci USA 1995;92:1142-6.
9. Ririe DG, Lundell JC, Neville MJ. Direct effects of propofol on myocardial and vascular tissue from mature and immature rats. J Cardiothorac Vasc Anesth 2001;15:745-9.
10. O'Neill PJ, Cobb LM, Ayala A, Morrison MH, Chaudry IH. Aggressive fluid resuscitation following intestinal ischemia-reperfusion in immature rats prevents metabolic derangements and down regulates interleukin-6 release. Shock 1994;1:381-7.
11. Wanstall JC, O'Donnell SR. Responses to vasodilator drugs on pulmonary artery preparations from pulmonary hypertensive rats. Br J Pharmacol 1992;105:152-8.
12. Wanstall JC, O'Donnell SR. Endothelin and 5-hydroxytryptamine on rat pulmonary artery in pulmonary hypertension. Eur J Pharmacol 1990;176:159-68.
13. Maruyama K, Maruyama J, Yokochi A, Muneyuki M, Miyasaka K. Vasodilatory effects of ketamine on pulmonary arteries in rats with chronic hypoxic pulmonary hypertension. Anesth Analg 1995;80:786-92.
14. Ishikawa M, Saito Y, Miyamoto Y, et al. cDNA cloning of rat cardiotrophin-1 (CT-1), augmented expression of CT-1 gene in ventricle of genetically hypertensive rats. Biochem Biophys Res Commun 1996;219:377-381.
15. Miller OI, Tang SF, Keech A, Pigott NB, Beller E, Celermajer DS. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. Lancet 2000;356:1464-9.
16. Goldman AP, Delius RE, Deanfield JE, de Leval MR, Sigston PE, Macrae DJ. Nitric oxide might reduce the need for extracorporeal support in children with critical postoperative pulmonary hypertension. Ann Thorac Surg 1996;62:750-5.
17. Day RW, Hawkins JA, McGough EC, Crezeé KL, Orsmond GS. Randomised controlled study of inhaled nitric oxide after operation for congenital heart disease. Ann Thorac Surg 2000;69:1907-13.
18. Lindberg L, Olsson AK, Jögi P, Jonmarker C. How common is severe pulmonary hypertension after pediatric cardiac surgery? J Thorac Cardiovasc Surg 2002;123:1155-63.
19. Takahashi T, Sakuma M, Ikeda J, et al. Effects and problems of continuous infusion of epoprostenol for patients with primary pulmonary hypertension. Intern Med 2002;41:784-8.
20. Funamoto M, Fujio Y, Kunisada K, et al. Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes. J Biol Chem 2000;275:10561-6.
21. Zachary I, Mathur A, Yla-Herttuala S, Martin J. Vascular protection: a novel, nonangiogenic cardiovascular role for vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 2000;20:1512-20.
22. Tsurumi Y, Murohata T, Krasinski K, et al. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 1997;3:879-86.
23. Barer G, Emery C, Stewart A, Bee D, Howard P. Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats. J Physiol 1993;463:1-16.
24. Hamanaka I, Saito Y, Nishikimi T, et al. Effects of cardiotrophin-1 on hemodynamics and endocrine function of the heart. Am J Physiol Heart Circ Physiol 2000;278:H388-96.
25. Meyrick B, Brigham KL. Acute effects of Escherichia coli endotoxin on the pulmonary microcirculation of anesthetized sheep structure: function relationships. Lab Invest 1983;48:458-70.
26. Meyrick B, Reid L. Hypoxia-induced structural changes in the media and adventitia of the rat hilar pulmonary artery and their regression. Am J Pathol 1980;100:151-78.
27. Mecham RP, Whitehouse LA, Wrenn DS, et al. Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. Science 1987;237:423-6.
28. Jin H, Yang R, Keller GA, et al. In vivo effects of cardiotrophin-1. Cytokine 1996;8:920-6.
29. Rabinovitch M, Gamble WJ, Miettinen OS, Reid L. Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. Am J Physiol 1981;240:H62-72.